NAGE vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

NAGE

50.2
AI Score
VS
NAGE Wins

CBIO

46.8
AI Score

Investment Advisor Scores

NAGE

50score
Recommendation
HOLD

CBIO

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NAGE CBIO Winner
Revenue 61.26M 1.04M NAGE
Net Income 7.28M -48.12M NAGE
Net Margin 11.9% -4631.4% NAGE
Operating Income 2.28M -51.09M NAGE
ROE 8.8% -29.5% NAGE
ROA 6.8% -26.3% NAGE
Total Assets 106.59M 182.76M CBIO
Current Ratio 6.50 9.66 CBIO

Relative Price Performance (Last 90 Days)

NAGE 1M: +0.6% · 3M: -15.3% CBIO 1M: +0.7% · 3M: -15.2%

Current Technical Phase

NAGE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.3 · Price: $3.21

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.0 · Price: $17.15

Fundamentals Snapshot

Metric NAGE CBIO
Market Cap
Forward P/E 32.1 -6.5
Trailing P/E 16.6
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.6% 1.0%
Operating Margin 0.0% -14.3%
EPS 0.19 -0.13
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NAGE is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.